Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 76.1% in September

Aethlon Medical, Inc. (NASDAQ:AEMD) saw a significant increase in short interest in September. As of September 30th, there was short interest totaling 94,200 shares, an increase of 76.1% from the September 15th total of 53,500 shares. Currently, 4.2% of the shares of the stock are sold short. Based on an average daily trading volume, of 2,980,000 shares, the short-interest ratio is currently 0.0 days. Based on an average daily trading volume, of 2,980,000 shares, the short-interest ratio is currently 0.0 days. Currently, 4.2% of the shares of the stock are sold short.

Analyst Ratings Changes

AEMD has been the topic of several recent analyst reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Aethlon Medical in a report on Wednesday, October 8th. HC Wainwright reiterated a “neutral” rating on shares of Aethlon Medical in a research report on Thursday, August 14th. Finally, Wall Street Zen upgraded Aethlon Medical to a “sell” rating in a report on Saturday, August 30th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Reduce” and an average target price of $560.00.

Hedge Funds Weigh In On Aethlon Medical

A hedge fund recently bought a new stake in Aethlon Medical stock. Armistice Capital LLC bought a new position in shares of Aethlon Medical, Inc. (NASDAQ:AEMD) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 1,427,946 shares of the medical equipment provider’s stock, valued at approximately $511,000. Armistice Capital LLC owned approximately 8.89% of Aethlon Medical at the end of the most recent quarter. 1.99% of the stock is currently owned by hedge funds and other institutional investors.

Aethlon Medical Trading Down 8.9%

Shares of AEMD stock opened at $5.02 on Wednesday. Aethlon Medical has a 1 year low of $4.92 and a 1 year high of $84.40. The firm’s 50 day moving average is $9.68 and its 200-day moving average is $17.73. The firm has a market capitalization of $1.31 million, a price-to-earnings ratio of -0.40 and a beta of 1.82.

Aethlon Medical (NASDAQ:AEMD) last announced its earnings results on Wednesday, August 13th. The medical equipment provider reported ($8.50) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($6.80) by ($1.70). On average, equities research analysts forecast that Aethlon Medical will post -0.73 earnings per share for the current fiscal year.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.